| abstract |
Disclosed are methods of treating psoriatic arthritis, IgA nephropathy, Hashimoto's disease, Sjogren's syndrome, ankylosing spondylitis, and uveitis in a mammal, involving administering to the mammal a therapeutically effective amount of an alpha-fetoprotein (AFP) or a biologically active fragment, derivative, or analog thereof. Compositions and kits containing an AFP or biologically active fragment, derivative, or analog thereof are also disclosed. |